Robeco Institutional Asset Management

Robeco Institutional Asset Management’s CRISPR Therapeutics CRSP Stock Holding History

Robeco Institutional Asset Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14,948	Closed	-$663K	–	970
2018 Q3	$663K	Sell	14,948 -16,064	-52%	-$841K	﹤0.01%	799
2018 Q2	$1.82M	Buy	+31,012	New	+$1.77M	0.01%	673

Other funds holding CRSP

Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return